Recerca

Àrea 4

Neurofarmacologia i Neuropatologia Experimental

Factor d'impacte: mitjana: 4.04, total: 125.27

Articles de l'any 2010
Original
  • Impulsivity Characterization in the Roman High- and Low-Avoidance Rat Strains: Behavioral and Neurochemical Differences

    Moreno M, Cardona D, Gomez MJ, Sanchez-Santed F, Tobena A, Fernandez-Teruel A, Campa L, Suñol C, Escarabajal MD, Torres C, Flores P
    NEUROPSYCHOPHARMACOL. 2010; 35: 1198-1208. IF: 6.993

  • Sonic-hedgehog-mediated proliferation requires the localization of PKA to the cilium base

    Barzi M, Berenguer J, Menendez A, Alvarez-Rodriguez R, Pons S
    J CELL SCI. 2010; 123: 62-69. IF: 6.144

  • Modified C-Reactive Protein Is Expressed by Stroke Neovessels and Is a Potent Activator of Angiogenesis In Vitro

    Slevin M, Matou-Nasri S, Turu M, Luque A, Rovira N, Badimon L, Boluda S, Potempa L, Sanfeliu C, DeVera N, Krupinski J
    BRAIN PATHOL. 2010; 20: 151-165. IF: 5.903

  • Matrix Metalloproteinase-9 and Cell Division in Neuroblastoma Cells and Bone Marrow Macrophages

    Sans-Fons MG, Sole S, Sanfeliu C, Planas AM
    AM J PATHOL. 2010; 177: 2870-2885. IF: 5.673

  • Self-assembled multifunctional Fe/MgO nanospheres for magnetic resonance imaging and hyperthermia

    Martinez-Boubeta C, Balcells L, Cristofol R, Sanfeliu C, Rodriguez E, Weissleder R, Lope-Piedrafita S, Simeonidis K, Angelakeris M, Sandiumenge F, Calleja A, Casas L, Monty C, Martinez B
    NANOMED-NANOTECHNOL. 2010; 6: 362-370. IF: 5.44

  • Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats

    Vidal R, Valdizan EM, Vilaro MT, Pazos A, Castro E
    BRIT J PHARMACOL. 2010; 161: 695-706. IF: 5.204

  • Preferential in vivo action of F15599, a novel 5-HT1A receptor agonist, at postsynaptic 5-HT1A receptors

    Llado-Pelfort L, Assie MB, Newman-Tancredi A, Artigas F, Celada P
    BRIT J PHARMACOL. 2010; 160: 1929-1940. IF: 5.204

  • Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase is regulated by acetylation

    Ventura M, Mateo F, Serratosa J, Salaet I, Carujo S, Bachs O, Pujol MJ
    INT J BIOCHEM CELL B. 2010; 42: 1672-1680. IF: 4.887

  • Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors

    Bortolozzi A, Masana M, Diaz-Mataix L, Cortes R, Scorza MC, Gingrich JA, Toth M, Artigas F
    INT J NEUROPSYCHOPH. 2010; 13: 1299-1314. IF: 4.874

  • Reduction of Glutamatergic Neurotransmission by Prolonged Exposure to Dieldrin Involves NMDA Receptor Internalization and Metabotropic Glutamate Receptor 5 Downregulation

    Briz V, Galofre M, Suñol C
    TOXICOL SCI. 2010; 113: 138-149. IF: 4.814

  • Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma

    Garcia I, Mayol G, Rodriguez E, Sunol M, Gershon TR, Rios J, Cheung NKV, Kieran MW, George RE, Perez-Atayde AR, Casala C, Galvan P, DeTorres C, Mora J, Lavarino C
    MOL CANCER. 2010; 9: 0-0. IF: 4.16

  • Serotonin 4 receptor (5-HT4R) internalization is isoform-specific: Effects of 5-HT and RS67333 on isoforms A and B

    Mnie-Filali O, Amraei MG, Berimbarek S, Archer-Lahlou E, Penas-Cazorla R, Vilaro MT, Boye SM, Pineyro G
    CELL SIGNAL. 2010; 22: 501-509. IF: 4.094

  • Inhibition of CCAAT/enhancer binding protein delta expression by chrysin in microglial cells results in anti-inflammatory and neuroprotective effects

    Gresa-Arribas N, Serratosa J, Saura J, Sola C
    J NEUROCHEM. 2010; 115: 526-536. IF: 3.999

  • Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice

    Scorza MC, Castane A, Bortolozzi A, Artigas F
    NEUROPHARMACOLOGY. 2010; 59: 112-120. IF: 3.909

  • In Vitro and In Vivo Activation of Astrocytes by Amyloid-beta is Potentiated by Pro-Oxidant Agents

    Garcia-Matas S, DeVera N, Aznar AO, Marimon JM, Adell A, Planas AM, Cristofol R, Sanfeliu C
    J ALZHEIMERS DIS. 2010; 20: 229-245. IF: 3.832

  • Ikaros-1 Couples Cell Cycle Arrest of Late Striatal Precursors With Neurogenesis of Enkephalinergic Neurons

    Martin-Ibanez R, Crespo E, Urban N, Sergent-Tanguy S, Herranz C, Jaumot M, Valiente M, Long JE, Pineda JR, Andreu C, Rubenstein JLR, Marin O, Georgopoulos K, Mengod G, Farinas I, Bachs O, Alberch J, Canals JM
    J COMP NEUROL. 2010; 518: 329-351. IF: 3.718

  • Methylmercury disrupts the balance between phosphorylated and non-phosphorylated cofilin in primary cultures of mice cerebellar granule cells A proteomic study

    Vendrell I, Carrascal M, Campos F, Abian J, Suñol C
    TOXICOL APPL PHARM. 2010; 242: 109-118. IF: 3.359

  • D2 AND D4 DOPAMINE RECEPTOR mRNA DISTRIBUTION IN PYRAMIDAL NEURONS AND GABAergic SUBPOPULATIONS IN MONKEY PREFRONTAL CORTEX: IMPLICATIONS FOR SCHIZOPHRENIA TREATMENT

    DeAlmeida J, Mengod G
    NEUROSCIENCE. 2010; 170: 1133-1139. IF: 3.292

  • GABA(A) receptor and cell membrane potential as functional endpoints in cultured neurons to evaluate chemicals for human acute toxicity

    Galofre M, Babot Z, Garcia DA, Iraola S, Rodriguez-Farre E, Forsby A, Suñol C
    NEUROTOXICOL TERATOL. 2010; 32: 52-61. IF: 3.274

  • Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats

    Castane A, Theobald DEH, Robbins TW
    BEHAV BRAIN RES. 2010; 210: 74-83. IF: 3.22

  • CCAAT/Enhancer Binding Protein Delta in Microglial Activationº

    Ejarque-Ortiz A, Gresa-Arribas N, Straccia M, Mancera P, Sola C, Tusell JM, Serratosa J, Saura J
    J NEUROSCI RES. 2010; 88: 1113-1123. IF: 2.986

  • Gene-environment interactions: Neurodegeneration in non-mammals and mammals

    Aschner M, Levin ED, Suñol C, Olopade JO, Helmcke KJ, Avila DS, Sledge D, Ali RH, Upchurch L, Donerly S, Linney E, Forsby A, Ponnuru P, Connor JR
    NEUROTOXICOLOGY. 2010; 31: 582-588. IF: 2.918

  • A Possible Role of the Non-GAT1 GABA Transporters in Transfer of GABA From GABAergic to Glutamatergic Neurons in Mouse Cerebellar Neuronal Cultures

    Suñol C, Babot Z, Cristofol R, Sonnewald U, Waagepetersen HS, Schousboe A
    NEUROCHEM RES. 2010; 35: 1384-1390. IF: 2.722

  • Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells

    DeGortari P, Mengod G
    BRAIN RES. 2010; 1310: 37-45. IF: 2.463

  • The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D

    Mori F, Perez-Torres S, DeCaro R, Porzionato A, Macchi V, Beleta J, Gavalda A, Palacios JM, Mengod G
    J CHEM NEUROANAT. 2010; 40: 36-42. IF: 1.753

  • EDUCA study: Psychometric properties of the Spanish version of the Zarit Caregiver Burden Scale

    Martin-Carrasco M, Otermin P, Perez-Camo V, Pujol J, Aguera L, Martin MJ, Gobartt AL, Pons S, Balana M
    AGING MENT HEALTH. 2010; 14: 705-711. IF: 1.127

Revisió
  • Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex

    Lopez-Gil X, Artigas F, Adell A
    CURR PHARM DESIGN. 2010; 16: 502-515. IF: 4.414

  • The prefrontal cortex: a target for antipsychotic drugs

    Artigas F
    ACTA PSYCHIAT SCAND. 2010; 121: 11-21. IF: 3.733

  • Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety

    Adell A
    IDRUGS. 2010; 13: 900-910. IF: 1.932

Editorials
  • Use of Gene Expression of Neural Markers in Cultured Neural Cells to Identify Developmental Neurotoxicants

    Suñol C
    TOXICOL SCI. 2010; 113: 1-3. IF: 4.814

  • New Strategies in the Search of Antipsychotic Drugs

    Adell A
    CURR PHARM DESIGN. 2010; 16: 486-487. IF: 4.414

Tornar